Expectorant Drugs Market

Expectorant Drugs Market

Expectorant Drugs Market Forecasts to 2030 - Global Analysis By Product (Prescription Drug and Over the Counter (Otc)), Dosage Form (Oral Solid, Oral Liquid and Inhalant), Drug Type, Distribution Channel, End User and By Geography

4.8 (60 reviews)
4.8 (60 reviews)
Published: 2024 ID: SMRC24844

This report covers the impact of COVID-19 on this global market

Years Covered


Estimated Year Value (2023)

US $17.16 BN

Projected Year Value (2030)

US $45.38 BN

CAGR (2023 - 2030)


Regions Covered

North America, Europe, Asia Pacific, South America, and Middle East & Africa

Countries Covered

US, Canada, Mexico, Germany, UK, Italy, France, Spain, Japan, China, India, Australia, New Zealand, South Korea, Rest of Asia Pacific, South America, Argentina, Brazil, Chile, Middle East & Africa, Saudi Arabia, UAE, Qatar, and South Africa

Largest Market

Asia Pacific

Highest Growing Market

North America

According to Stratistics MRC, the Global Expectorant Drugs Market is accounted for $17.16 billion in 2023 and is expected to reach $45.38 billion by 2030 growing at a CAGR of 14.9% during the forecast period. Expectorant drugs are medications primarily used to facilitate the removal of mucus and secretions from the airways, particularly in the respiratory tract. These drugs work by thinning and loosening mucus in the lungs, making it easier to cough up and expel. They are commonly used to alleviate symptoms associated with respiratory conditions such as cough, congestion, and respiratory infections.

According to data released by the National Center for Biotechnology Information, cough accounted for about 8% of all consultations with primary care physicians worldwide.

Market Dynamics: 


Rising prevalence of respiratory conditions

With an increasing number of individuals affected by respiratory ailments like bronchitis, COPD, asthma, and respiratory infections, the demand for medications, particularly expectorant drugs, rises correspondingly. These medications play a pivotal role in managing the hallmark symptoms of these conditions, such as excessive mucus production, coughing, and chest congestion. As respiratory illnesses become more commonplace due to factors like air pollution, changing lifestyles, and infectious agents, the consistent need for expectorant drugs to alleviate symptoms and improve respiratory health drives market growth.


Increased side effects

The market for expectorant drugs is severely constrained by the growing number of adverse effects. As these medications aim to alleviate respiratory symptoms by thinning mucus, the rise in reported adverse effects like nausea, dizziness, or allergic reactions impacts patient tolerance and compliance. Heightened occurrences of side effects can deter patient adherence, leading to reduced confidence in these medications and potentially affecting market demand.


Advancements in technology

Ongoing innovations drive the development of advanced drug formulations, improved delivery systems, and enhanced efficacy of expectorant medications. Novel technologies facilitate targeted drug delivery to affected respiratory areas, creating innovative formulations that optimise treatment outcomes and patient compliance. Additionally, advancements in personalised medicine and pharmacogenomics may lead to tailored expectorant therapies, ensuring more effective and personalised treatment approaches. Embracing these advancements addresses unmet medical needs, fostering growth and innovation in the expectorant drugs market.


Regulatory hurdles

Complex regulatory frameworks, diverse regional requirements, and extended approval timelines create obstacles for introducing new expectorant medications. Overcoming these hurdles demands substantial investments in research and development, meticulous adherence to stringent regulatory guidelines, and effective collaboration with regulatory bodies. Failure to navigate these challenges can impede the timely introduction of innovative expectorant drugs, limiting market growth.

Covid-19 Impact

There was a surge in demand for expectorant drugs due to the emphasis on managing respiratory symptoms associated with COVID-19, such as cough and chest congestion. The pandemic prompted increased research into respiratory health, potentially leading to the development of new and improved expectorant drugs or formulations. Furthermore, during the initial pandemic phase, there may be a continuing need for expectorant medications due to the COVID-19's long-lasting effects on respiratory health and possible long-term respiratory problems.

The mucolytics segment is expected to be the largest during the forecast period

The mucolytics segment is estimated to hold the largest share. Mucolytics contain agents such as bromhexine, acetylcysteine, or ambroxol that work by disrupting the chemical bonds within mucus, making it less viscous and easier to expel through coughing. Mucolytics find application in various respiratory conditions like chronic bronchitis, COPD (chronic obstructive pulmonary disease), and cystic fibrosis, aiding in the clearance of excessive mucus and alleviating symptoms of congestion. Furthermore, their ability to target and modify the properties of mucus makes them a crucial component in managing respiratory disorders. 

The hospitals segment is expected to have the highest CAGR during the forecast period

The hospitals segment is anticipated to have lucrative growth during the forecast period. Hospitals serve as major purchasers and distributors of expectorant drugs due to their role as primary centres for diagnosing and treating respiratory conditions. They procure a wide range of expectorant medications to manage patients with acute and chronic respiratory ailments, including pneumonia, bronchitis, and COPD exacerbations. In addition, hospitals maintain adequate stocks of these drugs to address the diverse respiratory health needs of patients admitted for respiratory care, emergency treatments, or chronic disease management, thereby significantly contributing to the demand within the expectorant drug market.

Region with largest share:

Asia Pacific commanded the largest market share during the extrapolated period due to rising respiratory ailments, increasing pollution levels, and a larger population affected by seasonal infections. Furthermore, factors like urbanisation, changing lifestyles, and environmental pollutants contribute to respiratory issues, driving the demand for expectorant medications. Initiatives for affordable healthcare access and the presence of key market players investing in research and development contribute to the region's burgeoning expectorant drug market, catering to the diverse respiratory health needs of the Asia Pacific population. 

Region with highest CAGR:

North America is expected to witness profitable growth over the projection period, due to prevalent conditions like bronchitis, flu, and allergies. The region's robust healthcare infrastructure, advanced pharmaceutical research, and high awareness levels among the population about managing respiratory health issues foster market growth. Moreover, strategic initiatives for drug development, strong regulatory frameworks, and the presence of key market players focusing on innovation and product diversification further propel the North American expectorant drug market. 

Key players in the market

Some of the key players in the Expectorant Drugs Market include Abbott Laboratories, Astrazeneca Plc., Acella Pharmaceuticals LLC, Cipla Limited, Beckman Coulter Inc., Mylan N.V., GSK plc, Glenmark Pharmaceuticals Limited, Johnson and Johnson, Novartis International AG, Merck KGaA, Pfizer inc, Sanofi SA, Vernalis plc, Proctor and Gamble Co, Dahur india Ltd, Teva Pharmaceutical Industries Ltd., Tris Pharma Inc., Aurobindo Pharma Ltd and Biocon.

Key Developments:

In October 2023, Efficient Laboratories, a Puerto Rican firm that distributes its brands of healthcare products, launched a new product, ROMPR PECHITO, an OTC medicine for children to relieve cold symptoms.

In September 2023, Genexa announced new clean over-the-counter (OTC) kids' medicines, further strengthening its leading role in bringing consumers clean, safe, and effective medications.

Products Covered:
• Prescription Drug
• Over the Counter (Otc)

Dosage Forms Covered:
• Oral Solid
• Oral Liquid
• Inhalant

Drug Types Covered:
• Secretion Enhancer
• Mucolytics
• Other Drug Types

Distribution Channels Covered:
• Drug Store
• Retail Store
• Online Pharmacies
• Other Distribution Channels

End Users Covered:
• Hospitals 
• Speciality Centres 
• Homecare 
• Other End Users 

Regions Covered:
• North America
o US
o Canada
o Mexico
• Europe
o Germany
o UK
o Italy
o France
o Spain
o Rest of Europe
• Asia Pacific
o Japan        
o China        
o India        
o Australia  
o New Zealand
o South Korea
o Rest of Asia Pacific    
• South America
o Argentina
o Brazil
o Chile
o Rest of South America
• Middle East & Africa 
o Saudi Arabia
o Qatar
o South Africa
o Rest of Middle East & Africa

What our report offers:
- Market share assessments for the regional and country-level segments
- Strategic recommendations for the new entrants
- Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements

Free Customization Offerings: 
All the customers of this report will be entitled to receive one of the following free customization options:
• Company Profiling
o Comprehensive profiling of additional market players (up to 3)
o SWOT Analysis of key players (up to 3)
• Regional Segmentation
o Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary      
2 Preface       
 2.1 Abstract      
 2.2 Stake Holders     
 2.3 Research Scope     
 2.4 Research Methodology    
  2.4.1 Data Mining    
  2.4.2 Data Analysis    
  2.4.3 Data Validation    
  2.4.4 Research Approach    
 2.5 Research Sources     
  2.5.1 Primary Research Sources   
  2.5.2 Secondary Research Sources   
  2.5.3 Assumptions    
3 Market Trend Analysis     
 3.1 Introduction     
 3.2 Drivers      
 3.3 Restraints     
 3.4 Opportunities     
 3.5 Threats      
 3.6 Product Analysis     
 3.7 End User Analysis     
 3.8 Emerging Markets     
 3.9 Impact of Covid-19     
4 Porters Five Force Analysis     
 4.1 Bargaining power of suppliers    
 4.2 Bargaining power of buyers    
 4.3 Threat of substitutes    
 4.4 Threat of new entrants    
 4.5 Competitive rivalry     
5 Global Expectorant Drugs Market, By Product   
 5.1 Introduction     
 5.2 Prescription Drug     
 5.3 Over The Counter (Otc)    
6 Global Expectorant Drugs Market, By Dosage Form   
 6.1 Introduction     
 6.2 Oral Solid     
 6.7 Oral Liquid     
 6.8 Inhalant      
7 Global Expectorant Drugs Market, By Drug Type   
 7.1 Introduction     
 7.2 Secretion Enhancer     
  7.2.1 Potassium Citrate    
  7.2.2 Sodium Citrate    
  7.2.3 Ammonium Chloride   
 7.3 Mucolytics     
  7.3.1 Bromhexine    
  7.3.2 Ambroxol    
  7.3.3 Carbocisteineurine    
  7.3.4 Acetyl Cysteine    
 7.4 Other Drug Types     
8 Global Expectorant Drugs Market, By Distribution Channel  
 8.1 Introduction     
 8.2 Drug Store     
 8.3 Retail Store     
 8.4 Online Pharmacies     
 8.5 Other Distribution Channels    
9 Global Expectorant Drugs Market, By End User   
 9.1 Introduction     
 9.2 Hospitals      
 9.3 Speciality Centres     
 9.4 Homecare     
 9.5 Other End Users     
10 Global Expectorant Drugs Market, By Geography   
 10.1 Introduction     
 10.2 North America     
  10.2.1 US     
  10.2.2 Canada     
  10.2.3 Mexico     
 10.3 Europe      
  10.3.1 Germany     
  10.3.2 UK     
  10.3.3 Italy     
  10.3.4 France     
  10.3.5 Spain     
  10.3.6 Rest of Europe    
 10.4 Asia Pacific     
  10.4.1 Japan     
  10.4.2 China     
  10.4.3 India     
  10.4.4 Australia     
  10.4.5 New Zealand    
  10.4.6 South Korea    
  10.4.7 Rest of Asia Pacific    
 10.5 South America     
  10.5.1 Argentina    
  10.5.2 Brazil     
  10.5.3 Chile     
  10.5.4 Rest of South America   
 10.6 Middle East & Africa    
  10.6.1 Saudi Arabia    
  10.6.2 UAE     
  10.6.3 Qatar     
  10.6.4 South Africa    
  10.6.5 Rest of Middle East & Africa   
11 Key Developments      
 11.1 Agreements, Partnerships, Collaborations and Joint Ventures 
 11.2 Acquisitions & Mergers    
 11.3 New Product Launch    
 11.4 Expansions     
 11.5 Other Key Strategies    
12 Company Profiling      
 12.1 Abbott Laboratories     
 12.2 Astrazeneca Plc.     
 12.3 Acella Pharmaceuticals LLC    
 12.4 Cipla Limited     
 12.5 Beckman Coulter Inc.    
 12.6 Mylan N.V.     
 12.7 GSK plc      
 12.8 Glenmark Pharmaceuticals Limited   
 12.9 Johnson and Johnson    
 12.10 Novartis International AG    
 12.11 Merck KGaA     
 12.12 Pfizer inc      
 12.13 Sanofi SA      
 12.14 Vernalis plc     
 12.15 Proctor and Gamble Co    
 12.16 Dahur india Ltd     
 12.17 Teva Pharmaceutical Industries Ltd.   
 12.18 Tris Pharma Inc.     
 12.19 Aurobindo Pharma Ltd    
 12.20 Biocon      
List of Tables       
1 Global Expectorant Drugs Market Outlook, By Region (2021-2030) ($MN) 
2 Global Expectorant Drugs Market Outlook, By Product (2021-2030) ($MN)
3 Global Expectorant Drugs Market Outlook, By Prescription Drug (2021-2030) ($MN)
4 Global Expectorant Drugs Market Outlook, By Over The Counter (Otc) (2021-2030) ($MN)
5 Global Expectorant Drugs Market Outlook, By Dosage Form (2021-2030) ($MN)
6 Global Expectorant Drugs Market Outlook, By Oral Solid (2021-2030) ($MN)
7 Global Expectorant Drugs Market Outlook, By Oral Liquid (2021-2030) ($MN)
8 Global Expectorant Drugs Market Outlook, By Inhalant (2021-2030) ($MN)
9 Global Expectorant Drugs Market Outlook, By Drug Type (2021-2030) ($MN)
10 Global Expectorant Drugs Market Outlook, By Secretion Enhancer (2021-2030) ($MN)
11 Global Expectorant Drugs Market Outlook, By Potassium Citrate (2021-2030) ($MN)
12 Global Expectorant Drugs Market Outlook, By Sodium Citrate (2021-2030) ($MN)
13 Global Expectorant Drugs Market Outlook, By Ammonium Chloride (2021-2030) ($MN)
14 Global Expectorant Drugs Market Outlook, By Mucolytics (2021-2030) ($MN)
15 Global Expectorant Drugs Market Outlook, By Bromhexine (2021-2030) ($MN)
16 Global Expectorant Drugs Market Outlook, By Ambroxol (2021-2030) ($MN)
17 Global Expectorant Drugs Market Outlook, By Carbocisteineurine (2021-2030) ($MN)
18 Global Expectorant Drugs Market Outlook, By Acetyl Cysteine (2021-2030) ($MN)
19 Global Expectorant Drugs Market Outlook, By Other Drug Types (2021-2030) ($MN)
20 Global Expectorant Drugs Market Outlook, By Distribution Channel (2021-2030) ($MN)
21 Global Expectorant Drugs Market Outlook, By Drug Store (2021-2030) ($MN)
22 Global Expectorant Drugs Market Outlook, By Retail Store (2021-2030) ($MN)
23 Global Expectorant Drugs Market Outlook, By Online Pharmacies (2021-2030) ($MN)
24 Global Expectorant Drugs Market Outlook, By Other Distribution Channels (2021-2030) ($MN)
25 Global Expectorant Drugs Market Outlook, By End User (2021-2030) ($MN)
26 Global Expectorant Drugs Market Outlook, By Hospitals (2021-2030) ($MN)
27 Global Expectorant Drugs Market Outlook, By Speciality Centres (2021-2030) ($MN)
28 Global Expectorant Drugs Market Outlook, By Homecare (2021-2030) ($MN)
29 Global Expectorant Drugs Market Outlook, By Other End Users (2021-2030) ($MN)
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.

List of Figures


Research Methodology

We at Stratistics opt for an extensive research approach which involves data mining, data validation, and data analysis. The various research sources include in-house repository, secondary research, competitor’s sources, social media research, client internal data, and primary research.

Our team of analysts prefers the most reliable and authenticated data sources in order to perform the comprehensive literature search. With access to most of the authenticated data bases our team highly considers the best mix of information through various sources to obtain extensive and accurate analysis.

Each report takes an average time of a month and a team of 4 industry analysts. The time may vary depending on the scope and data availability of the desired market report. The various parameters used in the market assessment are standardized in order to enhance the data accuracy.

Data Mining

The data is collected from several authenticated, reliable, paid and unpaid sources and is filtered depending on the scope & objective of the research. Our reports repository acts as an added advantage in this procedure. Data gathering from the raw material suppliers, distributors and the manufacturers is performed on a regular basis, this helps in the comprehensive understanding of the products value chain. Apart from the above mentioned sources the data is also collected from the industry consultants to ensure the objective of the study is in the right direction.

Market trends such as technological advancements, regulatory affairs, market dynamics (Drivers, Restraints, Opportunities and Challenges) are obtained from scientific journals, market related national & international associations and organizations.

Data Analysis

From the data that is collected depending on the scope & objective of the research the data is subjected for the analysis. The critical steps that we follow for the data analysis include:

  • Product Lifecycle Analysis
  • Competitor analysis
  • Risk analysis
  • Porters Analysis
  • PESTEL Analysis
  • SWOT Analysis

The data engineering is performed by the core industry experts considering both the Marketing Mix Modeling and the Demand Forecasting. The marketing mix modeling makes use of multiple-regression techniques to predict the optimal mix of marketing variables. Regression factor is based on a number of variables and how they relate to an outcome such as sales or profits.

Data Validation

The data validation is performed by the exhaustive primary research from the expert interviews. This includes telephonic interviews, focus groups, face to face interviews, and questionnaires to validate our research from all aspects. The industry experts we approach come from the leading firms, involved in the supply chain ranging from the suppliers, distributors to the manufacturers and consumers so as to ensure an unbiased analysis.

We are in touch with more than 15,000 industry experts with the right mix of consultants, CEO's, presidents, vice presidents, managers, experts from both supply side and demand side, executives and so on.

The data validation involves the primary research from the industry experts belonging to:

  • Leading Companies
  • Suppliers & Distributors
  • Manufacturers
  • Consumers
  • Industry/Strategic Consultants

Apart from the data validation the primary research also helps in performing the fill gap research, i.e. providing solutions for the unmet needs of the research which helps in enhancing the reports quality.

For more details about research methodology, kindly write to us at info@strategymrc.com

Frequently Asked Questions

In case of any queries regarding this report, you can contact the customer service by filing the “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929

Yes, the samples are available for all the published reports. You can request them by filling the “Request Sample” option available in this page.

Yes, you can request a sample with your specific requirements. All the customized samples will be provided as per the requirement with the real data masked.

All our reports are available in Digital PDF format. In case if you require them in any other formats, such as PPT, Excel etc you can submit a request through “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929

We offer a free 15% customization with every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.

We have 3 different licensing options available in electronic format.

  • Single User Licence: Allows one person, typically the buyer, to have access to the ordered product. The ordered product cannot be distributed to anyone else.
  • 2-5 User Licence: Allows the ordered product to be shared among a maximum of 5 people within your organisation.
  • Corporate License: Allows the product to be shared among all employees of your organisation regardless of their geographical location.

All our reports are typically be emailed to you as an attachment.

To order any available report you need to register on our website. The payment can be made either through CCAvenue or PayPal payments gateways which accept all international cards.

We extend our support to 6 months post sale. A post sale customization is also provided to cover your unmet needs in the report.

Request Customization

We provide a free 15% customization on every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.

Note: This customization is absolutely free until it falls under the 15% bracket. If your requirement exceeds this a feasibility check will be performed. Post that, a quote will be provided along with the timelines.


Assured Quality

Assured Quality

Best in class reports with high standard of research integrity

24X7 Research Support

24X7 Research Support

Continuous support to ensure the best customer experience.

Free Customization

Free Customization

Adding more values to your product of interest.

Safe and Secure Access

Safe & Secure Access

Providing a secured environment for all online transactions.

Trusted by 600+ Brands

Trusted by 600+ Brands

Serving the most reputed brands across the world.